Categories for Drug Litigation

A recent study has revealed that mothers who take Xarelto can pass down the drug to their unborn child. When ingested during pregnancy, the anticoagulant transfers back and forth across the placenta between a mother and her fetus. The study was done by a research team at The Motherisk Program at the Hospital for Sick Children in Toronto and published most recently in the American...

read more

Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has recently seen an increase in sales even as the drug continues to cause problems for a significant number of patients. In the first quarter of 2015, both Xarelto sales and J& J pharmaceutical division sales increased by 3% to $7.7 billion. Bayer has increased its forecast for Xarelto’s 2015 sales growth to...

read more

Xarelto, a relatively new prescription blood thinner, was first approved by the FDA in 2011 for patients who were at risk of developing blood clots as a result of knee or hip replacement surgeries. The marketers of the anticoagulant, Janssen Pharmaceuticals, aggressively marketed the drug as a “one-size-fits-all” drug. Given that, doctors readily prescribed the drug because it didn’t require them to monitor their patients...

read more

Foreign regulators in Australia are questioning whether additional blood monitoring on new anticoagulants would make the drugs safer. These drugs include Pradaxa, Eliquis and more specifically, Xarelto. The Australian Therapeutic Goods Administration recently announced this month that it had completed a review of new oral anticoagulants like Xarelto and have concluded that regular blood monitoring would not improve the drugs. The group came to this...

read more

According to a new study published recently by the Johns Hopkins Bloomberg School of Public Health and George Washington University, Xarelto, along with Pradaxa, may pose an increased risk of gastrointestinal bleeding in patients. Patients who instead choose to take warfarin, an older anticoagulant, appear to have a decreased change of experiencing these side effects. The study followed 46,000 patients that were given either Pardaxa,...

read more

This year has seen a significant increase in the number of law suits being brought against the manufacturers of Xarelto, Johnson & Johnson and Bayer Corp.. Individuals and their families allege that they have faced harmful negative side effects after taking the drug and that Johnson & Johnson and Bayer knew this, but still aggressively marketed their blockbuster drug to consumers. Dozens so far have...

read more

When Xarelto was first introduced to the general pharmaceutical company, it was touted as a much more convenient alternative to traditional blood thinners like warfarin. The drug was originally prescribed to patients who had undergone knee and hip replacement surgery and who were at a higher risk of blood clots following those procedures. The advantage, Bayer Healthcare claimed, was that patients would not have to...

read more

Bayer, the manufacturer of the blockbuster anticoagulant drug, Xarelto, is not only facing a significant number of lawsuits within the United States, but also abroad in other countries. Recently, a number of Canadian citizens have filed claims against Bayer, either on their own behalf or that of deceased family members. According to Toronto lawyer Bryan McPhadden, his firm has filed a lawsuit for the family...

read more

In 2012, Reuters published a piece that touched on the hesitancy that some doctors felt about a new generation of blood thinners, one of which was Xarelto. In 2011, the FDA had approved Xarelto for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip or knee replacement surgeries. A few months later, in November of 2011, the FDA approved it for a second use, for...

read more

In the March issue of the medical journal Academic Emergency Medicine, researchers from around the world found a disturbing correlation between the incidence of Xarelto-related bleeding in patients who are already at a higher risk for pulmonary embolism (PE). The study, sponsored by the manufacturers of Xarelto, Bayer HealthCare and Janssen, included about 5,000 patients at risk of pulmonary embolism. What they found was that...

read more

When Xarelto was first introduced to the market, doctors were quick to prescribe the medication because unlike it’s competition, warfarin, it didn’t require as much subsequent monitoring by the prescribing doctor. Now, as more individuals come forward and bring new civil law suits against its manufacturer, Bayer and Johnson & Johnson, doctors are become more reluctant to prescribe Xarelto. Both Xarelto and warfarin are anticoagulants...

read more

After Questcor, the pharmaceutical company behind Acthar, was acquired by Ireland’s Mallinckrodt, many questions began to be raised about the drug. One was the amount of money that Medicare has been paying for Acthar. In 2008, Medicare covered $141.5 million for the drug and in 2012, it covered around $220 million, increasing by almost double in just four years. Furthermore, in 2012, Medicare accounted for...

read more

Last month, it was made known that Bayer and Johnson & Johnson, the companies responsible for manufacturing the blood thinner Xarelto, are pushing for additional FDA approvals for their drug. Xarelto is already being prescribed to patients to treat blood clots, such as deep-vein thrombosis (DVT) and pulmonary embolus (PE), that occur more frequently in patients who have had certain types of surgeries, like knee...

read more

The American College of Obstetricians and Gynecologists recently released an article titled "What is New in the Use of Mesh in Vaginal Surgery?", which touched on some of the lingering effects that transvaginal mesh can have for women. One of the issues that the article also described was that of women who have remaining pain, even after troubling or painful mesh is removed. They state,...

read more

Recently, a judge found Ethicon, a division of Johnson & Johnson, liable for injuries that their Transvaginal Mesh Tape (TVT) Abbrevo caused one patient. The woman, identified as Coleen Perry, has been awarded $700,000 in compensatory damages and $5 million in punitive damages. The jury that was chosen to preside over the case deliberated for three days before reaching a verdict.  The plaintiff in this...

read more

Acthar, an expensive specialty drug prescribed to patients with various auto-immune and neurological diseases, has come under scrutiny in recent times for its severe and potentially deadly side effects. It’s also recently coming under more criticism because of the relationship many doctors have with its manufacturer, Questcor.  In 2012 alone, for example, 18 practitioners wrote 15 or more prescriptions for Acthar. At least 9 of...

read more

In February, Johnson & Johnson, one of the manufacturers of a TVM (transvaginal mesh) device, settled more than 100 lawsuits brought against them by consumer who had been hurt by the device. These particular cases were related to their Mentor unit manufactured transvaginal mesh tape and sling mesh devices.This particular mesh was discontinued in 2006, although Johnson & Johnson continues to allege that their device...

read more

Xarelto is one of the newest blood thinners on the market. It is prescribed to treat patients who are at risk of developing blood clots. However, Xarelto has recently received negative feedback from the pharmaceutical world because of its various side effects, the most common and most negative of them being an increased risk of internal bleeding. Patients who have brought civil lawsuits against the...

read more

Acthar is a prescription gel given to a wide variety of patients who suffer from different ailments. Among them are people with lupus, infants who suffer from infantile spasms, adults who are diagnosed with multiple sclerosis, and for other patients who deal with flares related to various other immune-related disorders. In July of 2014, the manufacturers of Acthar, Questcor Pharmaceuticals, submitted a regulatory filing that...

read more

It was recently announced that Bayer and Johnson & Johnson, the manufacturers of Xarelto, will continue to pursue additional FDA approvals for the drug, only this time, for stroke patients. Even as the two manufacturers continue to be hit with lawsuits by consumers who have been injured by the drug, they continue to pursue permission to market the drug for off-label use. Considering that there...

read more

On February 9th, 2015, JAMA Internal Medicine published an article stating that although the U.S. Food and Drug Administration (FDA) frequently finds problems with the way in which clinical sites perform biomedical research on human participants, this information is hardly ever distributed properly or adequately addressed when trials are published. Scientists who run these trials may be failing to adhere to good clinical practices and...

read more

Xarelto and FDA Approval

February 13, 2015

Xarelto is an anticoagulant drug approved by the Food and Drug Administration (“FDA”) for three primary uses—to treat patients who are at risk of developing blood clots after knee or hip replacement surgery, to treat those who are at risk of strokes, pulmonary embolism, and deep vein thrombosis and those who are experiencing atrial fibrillation. The Food and Drug Administration did not approve Xarelto to...

read more

Xarelto Health Risks

February 12, 2015

Xarelto is one of the newest blood thinners on the market. The anticoagulant drug is prescribed to patients who have experienced atrial fibulation, are at risk of developing severe blood clots after hip or knee replacement surgery and or to reduce the risk of strokes, pulmonary embolism and deep vein thrombosis. Xarelto is popular because it does not require patients to undergo blood tests to...

read more

Xarelto attorney leadership positions have been selected for the Xarelto lawsuits previously filed, consolidated, coordinated and assigned to Judge Eldon Fallon.  Out of 100 Xarelto injury lawsuits filed, Judge Fallon selected a group of plaintiffs’ attorneys to serve in a variety of leadership roles. Judge Fallon appointed twelve attorneys to leadership positions who are charged with various pretrial procedures including, but not limited to conducting...

read more

Tylenol is the most popular over-the-counter pain relief medication used by millions of people both in the United States and around the world to alleviate ailments such as aches, pain, colds, and fever. Manufactured by Johnson & Johnson, Tylenol contains an active ingredient, acetaminophen, which serves as a painkiller and is used by people of all ages.  Although people have considered Tylenol to be a...

read more

After a two week trial in state court in Dallas, Texas, the 12 person jury has reached a verdict Salazar v. Boston Scientific. The verdict comes after a mesh lawsuit was filed by Plaintiff, Martha Salazar, who was implanted with the Obtryx sling to treat urinary incontinence. During trial, evidence was presented showing that the implantation resulted in serious damage to her nerves and caused...

read more

Boston Scientific, one of several manufacturers of transvaginal mesh devices, has resumed trials in Massachusetts last week as it seeks to defend itself against plaintiffs who allege injury as a result of using the company’s transvaginal mesh. Industry watchers, pundits and plaintiffs alike are watching the trials closely, especially after Boston Scientific won its first big case last month, even as most juries erred on...

read more

In June of this year, the Journal of the American Medial Association (JAMA) released a study that linked the usage of Viagra to an increased development of skin cancer, or melanoma. The deadly skin disease is estimated to kill an estimated 9,710 people in the US annually. JAMA derived their data from an experiment that involved more than 25,000 men and controlled for factors such...

read more

In June of this year, the FDA released a warning to doctors and parents alike about the risk of using lidocaine solutions to numb the pain the babies and toddlers experience while teething. The FDA, along with many doctors, have warned parents to stop using medications that claim to do so as soon as possible. A medicated topical numbing gel that comes in either the form...

read more

In July of 2014, 21-year-old plaintiff Shaquil Byrd sued pharmaceutical company Johnson & Johnson, the manufacturers of the drug Risperdal, in the U.S. District Court for the Northern District of New York. After taking Risperdal, Byrd had developed gynecomastia in which men develop female breasts. He eventually required surgery to remove them.  Recently, it has come to light that the rare medical condition is associated...

read more

Public Citizen, a group that advocates on the behalf of consumers, has in the past petitioned the FDA to order a global recall of all transvaginal mesh products. Additionally, the petition asks the FDA to ban the marketing of any of the products, which are used to treat pelvic organ prolapsed. The FDA, in a letter dated from May of this year, has rejected both...

read more

A mother and her son have filed a lawsuit against Johnson & Johnson and Jansseen Pharmaceuticals, the makers and manufacturers of Risperdal. Mary Wasserman, mother to 26-year-old Andrew Wasserman, claims that Risperdal, prescribed to her son after medications failed, caused embarrassing and troubling side effects. Since starting to take the medication, Andrew has developed breasts as part of a condition called gynecomastia. He has had...

read more

The number of transvaginal mesh lawsuits has drastically increased in the past few months, as more and more women who have suffered as a result of the mesh have come forward. According to recent court documents, more than 50,000 transvaginal mesh lawsuits have been filed in the U.S. District Court, Southern District of West Virginia, by women who have been injured by a mesh product....

read more

  The FDA has released a new warning regarding both prescription and OTC (over-the-counter) oral viscous lidocaine solution, stating that it is not approved to treat teething pain and that health care providers should not prescribe the drug to children with teething pain. The agency now requires that a Boxed Warning, it’s most stringent warning, be placed on the labels of the drug. The new...

read more

After a JAMA study released in April of this year found that men who have taken Viagra have an 84% higher occurrence rate of melanoma, more doctors have spoken out, expressing a desire to see more research regarding this link. Dr. June Robinson of Northwestern University’s Feinberg School of Medicine originally wrote an accompanying editorial to the JAMA study which recommended further research to definitively...

read more

On April 10, 2014, the FDA sent a warning letter to American Medical Systems, one of the largest transvaginal mesh manufacturers in the country. The warning letter came after the FDA inspected the company’s plant and found several issues that were related to risk analysis and other quality control problems. Although AMS has since responded and claimed that it would be implanting a corrective action...

read more

The FDA recently announced that they are now requiring a change in the warnings on testosterone products such as Androgel and Androderm. These new warnings are required by law to be more general and warn users of the risk of blood clots. Prior to this announcement, testosterone replacement therapy drugs were only required to include warnings related to polycythemia, a medical issue that occurs due...

read more

A recent study by JAMA released in April of this year has found that men who take Viagra, the popular drug prescribed for erectile dysfunction, have an shocking 84% risk of developing melanoma, the deadly skin cancer. The study tracked more than 25,000 men who were on average around the age of 65 and who had taken the drug within 3 months. What they found was that...

read more

As of June of this year, more than 11,000 lawsuits Yasmin and Yaz lawsuits have been filed against Bayer Pharmaceuticals, the makers of the popular birth control. These lawsuits have been filed in the U.S. District Court, Southern District of Illinois and of the 11,677 lawsuits currently filed, 9,055 are currently pending litigation.  According to court documents and complaints from patients, the birth control has...

read more

After its entry into the pharmaceutical market in 1998, Viagra, the famous "little blue pill", exploded in sales. Today, it’s yearly revenue exceeds $2 billion. Unfortunately, the manufacturer of Viagra, Pfizer, is coming under increasing scrutiny as thousands of men are being diagnosed with melanoma, a form of skin cancer, after taking the drug.  Recent research by JAMA has linked this potentially deadly side effect to...

read more

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consultation

Live Chat (Online Now)